Form D · Pharmaceuticals
Absorption Pharmaceuticals, LLC
Las Vegas, NV · CIK 0001549050
Offering snapshot reported Feb 14, 2014 · SEC filing
- Reported sold
- $1.2M Offering amount: $1.2M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 8, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2014 | Initial | $1,200,000 | No comparison | 17 | SEC filing |
| May 4, 2012 | Initial | $561,982 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212026
Source: Form D, filed Feb 14, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Alan Abraham | Director, Executive |
| Nick Elias Abraham | Executive |
| Ron Franklin Gilbert | Executive |
| William Kuser | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
42 Sun Glow Lane
Las Vegas, NV, 89135
Las Vegas, NV, 89135